Target intelligence / Profile preview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 21 (EEF1A1P21)

Target: EEF1A1P21
Molecular classification: Other (Pseudogene)

Overview

Eukaryotic translation elongation factor 1 alpha 1 pseudogene 21 (EEF1A1P21) is classified as a processed pseudogene in the human genome, located on chromosome 4 (4p15.1), with a length of 1339 nucleotides. Pseudogenes like EEF1A1P21 are nonfunctional, paralogous genomic sequences derived from ancestral protein-coding genes (in this case, EEF1A1, which encodes a crucial protein in translation elongation). EEF1A1P21 does not encode a protein product, shows no established biological function, and current literature provides no evidence for its involvement in any regulatory or disease-specific mechanisms beyond its mention in some genomic association studies of cancer. It is not considered a therapeutic target and has no known molecular interactions, roles in pathophysiology, or drug associations[1][2][4].

Other names: EEF1A1P21

Mechanism of action

None (no known mechanism as this is not a protein-coding or functional molecule)

Biological functions

None (no protein product; not known to have a biological function)

Disease associations

Other (EEF1A1P21 is catalogued as present in the genome and referenced in some disease association surveys for *oral squamous cell carcinoma*, but there is no direct functional evidence or mechanistic implication; its parental gene EEF1A1 is widely studied in cancer and other diseases)

Safety considerations

None (not a therapeutic target; no safety profile required)

Interacting drugs

None (no drug interactions known or reported)

Biomarkers

None (pseudogenes generally are not used as biomarkers unless expression is reported; for EEF1A1P21, no such reports exist)

Beyond the preview

Go deeper on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 21 (EEF1A1P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation elongation factor 1 alpha 1 pseudogene 21 (EEF1A1P21).

Explore the full profile